These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16199376)

  • 21. Uptake of long-circulating immunoliposomes, directed against colon adenocarcinoma cells, by liver metastases of colon cancer.
    Kamps JA; Koning GA; Velinova MJ; Morselt HW; Wilkens M; Gorter A; Donga J; Scherphof GL
    J Drug Target; 2000; 8(4):235-45. PubMed ID: 11144234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody-directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody.
    Ríhová B; Kopecková P; Strohalm J; Rossmann P; Vĕtvicka V; Kopecek J
    Clin Immunol Immunopathol; 1988 Jan; 46(1):100-14. PubMed ID: 2891460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting of ICAM-1-directed immunoliposomes specifically to activated endothelial cells with low cellular uptake: use of an optimized procedure for the coupling of low concentrations of antibody to liposomes.
    Hua S; Chang HI; Davies NM; Cabot PJ
    J Liposome Res; 2011 Jun; 21(2):95-105. PubMed ID: 20429814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid composition is important for highly efficient target binding and retention of immunoliposomes.
    Maruyama K; Kennel SJ; Huang L
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5744-8. PubMed ID: 2377612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptor.
    Kang YS; Bickel U; Pardridge WM
    Drug Metab Dispos; 1994; 22(1):99-105. PubMed ID: 8149897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers.
    Shao M; Sun SL; Li MH; Li BX; Yu H; Shen ZY; Ren YC; Hao ZF; Chang ND; Peng HS; Yang BF
    J Liposome Res; 2012 Jun; 22(2):168-76. PubMed ID: 22428938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-neuropilin 1 antibody Fab' fragment conjugated liposomal docetaxel for active targeting of tumours.
    Manjappa AS; Goel PN; Gude RP; Ramachandra Murthy RS
    J Drug Target; 2014 Sep; 22(8):698-711. PubMed ID: 24766186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system.
    Wu D; Boado RJ; Pardridge WM
    J Pharmacol Exp Ther; 1996 Jan; 276(1):206-11. PubMed ID: 8558431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of verapamil on the pharmacokinetics of daunomycin in the rat.
    Nooter K; Oostrum R; Deurloo J
    Cancer Chemother Pharmacol; 1987; 20(2):176-8. PubMed ID: 3664935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
    Markoutsa E; Pampalakis G; Niarakis A; Romero IA; Weksler B; Couraud PO; Antimisiaris SG
    Eur J Pharm Biopharm; 2011 Feb; 77(2):265-74. PubMed ID: 21118722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Targeted Delivery to the Brain Using Magnetic Immunoliposomes and Magnetic Force.
    Thomsen LB; Linemann T; Birkelund S; Tarp GA; Moos T
    Materials (Basel); 2019 Oct; 12(21):. PubMed ID: 31683542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes.
    Gagné JF; Désormeaux A; Perron S; Tremblay MJ; Bergeron MG
    Biochim Biophys Acta; 2002 Feb; 1558(2):198-210. PubMed ID: 11779569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the cellular uptake of E-Selectin-targeted immunoliposomes by activated human endothelial cells.
    Kessner S; Krause A; Rothe U; Bendas G
    Biochim Biophys Acta; 2001 Oct; 1514(2):177-90. PubMed ID: 11557019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PEGylated immunoliposomes directed against brain astrocytes.
    Chekhonin VP; Zhirkov YA; Gurina OI; Ryabukhin IA; Lebedev SV; Kashparov IA; Dmitriyeva TB
    Drug Deliv; 2005; 12(1):1-6. PubMed ID: 15801714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
    Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of in vivo immunoliposome targeting to pulmonary endothelium.
    Maruyama K; Holmberg E; Kennel SJ; Klibanov A; Torchilin VP; Huang L
    J Pharm Sci; 1990 Nov; 79(11):978-84. PubMed ID: 2292774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro cellular accumulation and cytotoxicity of liposomal and conventional formulations of daunorubicin and doxorubicin in resistant K562 cells.
    Wang Y; Eksborg S; Lewensohn R; Lindberg A; Liliemark E
    Anticancer Drugs; 1999 Nov; 10(10):921-8. PubMed ID: 10630360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model.
    Mori A; Kennel SJ; van Borssum Waalkes M; Scherphof GL; Huang L
    Cancer Chemother Pharmacol; 1995; 35(6):447-56. PubMed ID: 7882453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetically engineered brain drug delivery vectors: cloning, expression and in vivo application of an anti-transferrin receptor single chain antibody-streptavidin fusion gene and protein.
    Li JY; Sugimura K; Boado RJ; Lee HJ; Zhang C; Duebel S; Pardridge WM
    Protein Eng; 1999 Sep; 12(9):787-96. PubMed ID: 10506289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of differently designed immunoliposome formulations in rats with or without hepatic colon cancer metastases.
    Koning GA; Morselt HW; Gorter A; Allen TM; Zalipsky S; Kamps JA; Scherphof GL
    Pharm Res; 2001 Sep; 18(9):1291-8. PubMed ID: 11683242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.